| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.39(B) |
| Last
Volume: |
264,180 |
Avg
Vol: |
496,145 |
| 52
Week Range: |
$71.24 - $97.37 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,812 |
31,812 |
49,488 |
112,090 |
| Total Sell Value |
$2,869,033 |
$2,869,033 |
$4,436,322 |
$9,328,076 |
| Total People Sold |
4 |
4 |
5 |
9 |
| Total Sell Transactions |
11 |
11 |
15 |
30 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Meelia Richard J |
Director |
• • – |
2016-07-21 |
4 |
A |
$29.59 |
$169,995 |
D/D |
5,746 |
22,626 |
|
- |
|
| Merriman Ronald |
Director |
• • – |
2016-07-21 |
4 |
A |
$29.59 |
$169,995 |
D/D |
5,746 |
22,188 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2016-07-21 |
4 |
A |
$29.59 |
$169,995 |
D/D |
5,746 |
55,271 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2016-06-29 |
4 |
A |
$0.01 |
$459 |
D/D |
45,867 |
45,867 |
|
- |
|
| Selman Byron |
President, Global Markets |
• • – |
2016-01-13 |
4 |
A |
$0.01 |
$81 |
D/D |
8,138 |
20,148 |
|
- |
|
| Ryding Neil 122-62-507 |
EVP, Global Manufacturing |
• • – |
2016-01-13 |
4 |
A |
$0.01 |
$98 |
D/D |
9,765 |
13,987 |
|
- |
|
| Fusco David |
EVP, Global Human Resources |
• • – |
2016-01-13 |
4 |
A |
$0.01 |
$81 |
D/D |
8,138 |
13,553 |
|
- |
|
| Jesse Sandra |
EVP and Chief Legal Officer |
• • – |
2016-01-13 |
4 |
A |
$0.01 |
$98 |
D/D |
9,765 |
29,861 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• • – |
2016-01-13 |
4 |
A |
$0.01 |
$114 |
D/D |
11,393 |
56,743 |
|
- |
|
| Selman Byron |
President, Global Markets |
• • – |
2015-10-26 |
4 |
S |
$32.13 |
$11,052 |
D/D |
(344) |
12,010 |
|
- |
|
| White Jonathan |
Chief Science and Technology |
• • – |
2015-10-26 |
4 |
S |
$32.13 |
$10,249 |
D/D |
(319) |
30,507 |
|
- |
|
| Jesse Sandra |
EVP and Chief Legal Officer |
• • – |
2015-10-26 |
4 |
S |
$32.13 |
$24,996 |
D/D |
(778) |
20,096 |
|
- |
|
| Hanlon Susan M |
VP Finance |
• • – |
2015-10-26 |
4 |
S |
$32.13 |
$15,968 |
D/D |
(497) |
20,464 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• • – |
2015-10-26 |
4 |
S |
$32.13 |
$14,008 |
D/D |
(436) |
45,350 |
|
- |
|
| Burns Brian R |
EVP, Global QA/RA |
• • – |
2015-10-23 |
4 |
S |
$31.75 |
$7,906 |
D/D |
(249) |
16,235 |
|
- |
|
| White Jonathan |
Chief Science and Technology |
• • – |
2015-10-23 |
4 |
S |
$31.75 |
$7,937 |
D/D |
(250) |
29,848 |
|
- |
|
| Davies Kent J |
Chief Operating Officer |
• • – |
2015-10-23 |
4 |
S |
$31.75 |
$8,826 |
D/D |
(278) |
16,891 |
|
- |
|
| Selman Byron |
President, Global Markets |
• • – |
2015-10-23 |
4 |
S |
$31.75 |
$6,064 |
D/D |
(191) |
11,296 |
|
- |
|
| Jesse Sandra |
EVP and Chief Legal Officer |
• • – |
2015-10-23 |
4 |
S |
$31.75 |
$7,937 |
D/D |
(250) |
18,486 |
|
- |
|
| Hanlon Susan M |
VP Finance |
• • – |
2015-10-23 |
4 |
S |
$31.75 |
$5,143 |
D/D |
(162) |
19,437 |
|
- |
|
| White Jonathan |
Chief Science and Technology |
• • – |
2015-10-20 |
4 |
A |
$0.01 |
$41 |
D/D |
4,105 |
29,333 |
|
- |
|
| Burns Brian R |
EVP, Global QA/RA |
• • – |
2015-10-20 |
4 |
A |
$0.01 |
$39 |
D/D |
3,909 |
15,719 |
|
- |
|
| Fusco David |
EVP, Global Human Resources |
• • – |
2015-10-20 |
4 |
A |
$0.01 |
$27 |
D/D |
2,736 |
5,415 |
|
- |
|
| Jesse Sandra |
EVP and Chief Legal Officer |
• • – |
2015-10-20 |
4 |
A |
$0.01 |
$33 |
D/D |
3,323 |
17,971 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• • – |
2015-10-20 |
4 |
A |
$0.01 |
$63 |
D/D |
6,255 |
44,443 |
|
- |
|
594 Records found
|
|
Page 18 of 24 |
|
|
1.77 (2.03%) 
